Investor Alert: Pomerantz Law Firm Investigates Celcuity Inc.
The Pomerantz Law Firm is investigating potential securities fraud or unlawful business practices by Celcuity Inc. (NASDAQ: CELC) and its officers following a delayed commercial launch of their FDA-approved breast cancer therapy, Revtorpyk. The stock price dropped significantly after the announcement.
Tickers: $CELC
Topics: class action FDA approval securities fraud stock price drop